Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Stock of the day: Fisher and Paykel Healthcare

Fisher & Paykel Healthcare reports a 43% increase in net profit to $153.2 million for the first half of 2025, despite stock pressures. Operating revenue rose 18%, with strategic focus maintaining growth post-Covid-19.

Video poster image

(AI video summary)

This video was created on 28 November for IG audiences by ausbiz.

ASX code: FPH

Fisher & Paykel's performance highlights

Fisher & Paykel Healthcare reported a 43% increase in net profit for the first half (H1) of the 2025 financial year, reaching $153.2 million. While, operating revenue rose 18% to $951.2 million. The company reaffirmed its full-year net profit guidance of $320 million to $370 million.

Despite positive results, the stock has faced pressure, though it is up about 52% year-to-date.

Price-to-earnings ratio considerations

The stock's high price-to-earnings (P/E) ratio is a concern for investors. It was at 103 before the announcement, and even a 40% profit increase would only lower it to 60.

Historically, investors like Howard bought when the P/E was 20 to 25. This suggests holding shares rather than buying more at the current valuation.

Market expectations and outlook

The Covid-19 pandemic set high expectations, impacting market reactions. Fisher & Paykel saw increased demand for masks and healthcare equipment during the pandemic. Post-pandemic, the healthcare sector shifted focus, but the company maintained growth through effective cost management.

With its current valuation, analysts have a hold rating.

Discover our powerful trading platforms and tools.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Explore the markets with our free course

Discover and learn how the range of markets you can trade on with IG Academy's online course – ‘Introducing the financial markets’.

Try IG Academy

Put learning into action

Try out what you’ve learned in this shares strategy article risk-free in your demo account.

Try it out

Ready to trade shares?

Put the lessons in this article to use in a live account – upgrading is quick and easy.

  • Trade on over 10,000 popular global stocks
  • Protect your capital with risk management tools
  • React to breaking news with out-of-hours trading on 70 key US stocks
Create live account

Inspired to trade?

Put your new knowledge into practice. Log in to your account now.

Log in now

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

<h3>How much does trading cost?</h3>
<h3>Find out about IG</h3>
<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.